Interested in sharing the research? You can order print copies of many research publications.

Order Reprints

Newsletter Sign-Up

Keep up to date with NPC news and events by signing up for our e-newsletter E.V.I.dently, and our CER Daily Newsfeed.

Subscribe POLICY

Does The Work Of The National Institute For Health And Clinical Excellence (NICE) Have Any Relevance For The United States?

Does The Work Of The National Institute For Health And Clinical Excellence (NICE) Have Any Relevance For The US?

The growing emphasis on evidence-based decision-making in health care, especially regarding health technologies, has generated notable debate and discussion in the U.S. around establishing a more formalized process or system for conducting comparative effectiveness research. In the eyes of many observers, this is quite similar to the health technology assessment programs existing in a number of European countries. The National Institute for Health and Clinical Excellence (NICE) in the U.K. is one the most discussed and debated systems currently in operation, since it represents one of the most sophisticated national attempts to systematically review the value, or relative costs and benefits, of various treatments. The National Pharmaceutical Council commissioned a study of NICE in order to understand its methods of working and to explore its relevance to the United States.

Blog Post

CER Tweets of the Week: PCORI’s Selby to Speak at CTSI Symposium, PIPC Annual Forum; Cochrane Consumer Network Training (November 17-21)

Upcoming and past events garnered attention among comparative effectiveness research (CER) stakeholders this week. They tweeted about the University...
Newsletter Volume

E.V.I.dently November 2014

NPC MessageMind the Gap (and Engage Patients in the Quality Measure Conversation)When it comes to quality measures, we don’t often talk about them in...
Blog Post

Specialty Pharmaceutical and Patient Care: Are We at a Tipping Point?

Last month, the Academy of Managed Care Pharmacy (AMCP) Foundation hosted a symposium, “Specialty Pharmaceutical and Patient Care: Are We at a...
Blog Post

CER Tweets of the Week: #OHRP’s Informed Consent Guidelines, @AHRQNews On Real-World Primary Care Evaluation (November 10-14)

This week on Twitter, comparative effectiveness research (CER) stakeholders shared the New England Journal of Medicine’s (@NEJM) paper on the concept...
Press Release

Fellowship in Health Care Policy Available Through a Partnership of the National Pharmaceutical Council and Milken Institute School of Public Health at The George Washington University

WASHINGTON, DC (September 17, 2014)–The National Pharmaceutical Council (NPC), in conjunction with Milken Institute School of Public Health (Milken...
Press Release

NPC Study Outlines When & How Health Decision-Makers Should Consider Individual Patient Differences

Washington, DC (July 29, 2014)—New research led by the National Pharmaceutical Council (NPC) can assist health care stakeholders to understand when...
Press Release

NPC Annual Stakeholder Survey: Comparative Effectiveness Research Is Important, But Impact on Health Care Decision-Making Is Still on the Horizon

(Washington, DC, May 19, 2014)—A new survey of health care stakeholders reveals continued optimism for the use of comparative effectiveness research...
Press Release

CER Collaborative Improving Health Outcomes Through New Comparative Evidence Tools

(Washington, DC, March 24, 2014)—Three peer-reviewed articles published in Value in Health offer important guidance to aid formulary decision-makers...
Commentary and Testimony Page

NPC Comments on PCORI Proposal for Peer Review of Primary Research and Public Release of Research Findings

November 7, 2014Dr. Joe SelbyExecutive DirectorPatient-Centered Outcomes Research Institute1828 L St., NW, Suite 900Washington, DC 20036Dear Dr....
Commentary and Testimony Page

The State of CER and the Environment for Health Care Decision Making

This month, NPC released its third annual survey on stakeholders’ views on comparative effectiveness research (CER), “The State of Comparative...
Commentary and Testimony Page

Keeping Our Eye on the CER Ball

Until the cherry blossoms begin to bloom later next month, most of the water cooler conversations in Washington will focus on the federal budget....
Commentary and Testimony Page

Leveling the Playing Field? Could a Landmark Decision Alter the CER Communications Landscape?

A growing chorus of voices is publicly sharing data on the effectiveness of treatment options, but one viewpoint has long been shut out of key areas...
YouTube Videos

Differences in Global Health Technology Assessment

David Grainger, senior director, global public policy, Eli Lilly and Company, describes how health technology assessment (HTA) informs policy and...
YouTube Videos

Incorporating Patient Views Into Health Technology Assessments

David Grainger, senior director, global public policy, Eli Lilly and Company, explains that many health technology assessments are incorporating...
YouTube Videos

Health Technology Assessments and Specialty Medications

David Grainger, senior director, global public policy, Eli Lilly and Company, says that there are often challenges in conducting health technology...
YouTube Videos

Real-World Impact of Comparative Effectiveness Research Findings on Clinical Practice

National Pharmaceutical Council Chief Science Officer Robert W. Dubois, MD, PhD, discusses a peer-reviewed study suggesting that changes are needed...
Blog Post

CER Tweets of the Week: PCORI’s Selby to Speak at CTSI Symposium, PIPC Annual Forum; Cochrane Consumer Network Training (November 17-21)

Upcoming and past events garnered attention among comparative effectiveness research (CER) stakeholders this week. They tweeted about the University...
Blog Post

Specialty Pharmaceutical and Patient Care: Are We at a Tipping Point?

Last month, the Academy of Managed Care Pharmacy (AMCP) Foundation hosted a symposium, “Specialty Pharmaceutical and Patient Care: Are We at a...
Blog Post

CER Tweets of the Week: #OHRP’s Informed Consent Guidelines, @AHRQNews On Real-World Primary Care Evaluation (November 10-14)

This week on Twitter, comparative effectiveness research (CER) stakeholders shared the New England Journal of Medicine’s (@NEJM) paper on the concept...
Blog Post

CER Tweets of the Week: #ISPORAmst, PCORI and Health Affairs to Talk Patient Engagement (November 3-7)

What were comparative effectiveness research (CER) stakeholders tweeting about this week? We saw a lot of chatter about the International Society for...

Research

  •  
  • 1 of 41
  • >

Commentary & Testimony